ArthurSantoraMD
Endocrinology • New Brunswick, NJDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid
Clinical Associate Professor
Dr. Santora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Paterson St
Clinical Academic Building - Suite 5200a
New Brunswick, NJ 08901Phone+1 732-235-7219
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1984
Emory University School of MedicineResidency, Internal Medicine, 1978 - 1981- Emory University School of MedicineClass of 1978
Certifications & Licensure
NJ State Medical License 1989 - 2025
MI State Medical License 1986 - 2020
GA State Medical License 1980 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 3 citationsOral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study.Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, Vanessa Rouach, Chana Sternberg
Journal of Bone and Mineral Research. 2024-07-23 - 12 citationsIncidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture TrialSocrates E. Papapoulos, Henry G. Bone, Felicia Cosman, David W. Dempster, Michael R. McClung
Journal of Bone and Mineral Research. 2021-04-27 - 2 citationsEarly changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysisKenneth G. Saag, Felicia Cosman, T. J. de Villiers, Bente L. Langdahl, Boyd B. Scott
Osteoporosis International. 2021-02-19
Journal Articles
- Open-Label Study of Treatment with Alendronate Sodium plus Vitamin D in Men and Women with Osteoporosis in ThailandArthur Santora, MD, BioMed Central
Press Mentions
Chutes & Ladders—Curis Moves up COO as CEO Fattaey DepartsSeptember 28th, 2018- Former Merck Clinical Research VP Arthur Santora Joins Entera Bio as CMOSeptember 24th, 2018
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenMarch 18th, 2004
Professional Memberships
- American Society for Bone and Mineral ResearchMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
